ES2091322T3 - Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa. - Google Patents

Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa.

Info

Publication number
ES2091322T3
ES2091322T3 ES91906818T ES91906818T ES2091322T3 ES 2091322 T3 ES2091322 T3 ES 2091322T3 ES 91906818 T ES91906818 T ES 91906818T ES 91906818 T ES91906818 T ES 91906818T ES 2091322 T3 ES2091322 T3 ES 2091322T3
Authority
ES
Spain
Prior art keywords
compounds
dna
emooding
bencillated
alkylguanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91906818T
Other languages
English (en)
Spanish (es)
Inventor
Robert Carl Moschel
Mary Eileen Dolan
Anthony E Pegg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Department of Commerce
US Department of Health and Human Services
Original Assignee
United States Department of Commerce
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/492,468 external-priority patent/US5091430A/en
Application filed by United States Department of Commerce, US Department of Health and Human Services filed Critical United States Department of Commerce
Application granted granted Critical
Publication of ES2091322T3 publication Critical patent/ES2091322T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91906818T 1990-03-13 1991-03-13 Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa. Expired - Lifetime ES2091322T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/492,468 US5091430A (en) 1990-03-13 1990-03-13 O6 -substituted guanine compounds and methods for depleting O6 -alkylguanine-DNA alkyltransferase levels
US07/616,913 US5352669A (en) 1990-03-13 1990-11-21 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity

Publications (1)

Publication Number Publication Date
ES2091322T3 true ES2091322T3 (es) 1996-11-01

Family

ID=27050758

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91906818T Expired - Lifetime ES2091322T3 (es) 1990-03-13 1991-03-13 Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa.

Country Status (10)

Country Link
US (1) US5352669A (en, 2012)
EP (1) EP0523100B1 (en, 2012)
JP (1) JP2829440B2 (en, 2012)
AT (1) ATE141925T1 (en, 2012)
CA (1) CA2078129C (en, 2012)
DE (1) DE69121706T2 (en, 2012)
DK (1) DK0523100T3 (en, 2012)
ES (1) ES2091322T3 (en, 2012)
GR (1) GR3021277T3 (en, 2012)
WO (1) WO1991013898A1 (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5691307A (en) * 1990-03-13 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services O6 -substituted guanine compositions and methods for depleting O6
GB9015914D0 (en) * 1990-07-19 1990-09-05 Wellcome Found Heterocyclic compounds
ZA94248B (en) * 1993-01-14 1994-07-13 Cancer Res Campaign Tech Potentiation of temozolomide in human tumour cells
RU2154646C2 (ru) * 1993-06-08 2000-08-20 Кэнсер Рисерч Кэмпейн Текнолоджи Лимитед Производные о6-алкилгуанина и фармацевтическая композиция
US6043228A (en) * 1993-06-08 2000-03-28 Cancer Research Campaign Technology Limited O6 -substituted guanine derivatives, a process for their preparation and their use in treating tumor cells
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
US5525606A (en) 1994-08-01 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines
US5965126A (en) * 1996-03-25 1999-10-12 The Penn State Research Foundation use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
US6060458A (en) * 1998-02-13 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
WO2003084957A1 (en) * 2002-04-08 2003-10-16 Sumika Fine Chemicals Co., Ltd. Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof
KR20050062588A (ko) * 2002-10-03 2005-06-23 에콜 폴리테크니크 페데랄레 드 로잔 O6-알킬구아닌-dna 알킬트랜스퍼라제용 기질
AU2004313931A1 (en) * 2004-01-06 2005-07-28 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services 2-amino-O4-substituted pteridines and their use as inactivators of O6-alkylguanine-DNA alkyltransferase
US7825096B2 (en) * 2004-09-08 2010-11-02 The United States Of America As Represented By The Department Of Health And Human Services O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
CN100526315C (zh) 2005-06-16 2009-08-12 浙江医药股份有限公司新昌制药厂 N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
WO2008137207A2 (en) * 2007-05-02 2008-11-13 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Inactivators of o6-alkylguanine-dna alkyltransferase
CN107098906B (zh) * 2017-05-19 2020-05-05 四川大学 苄基鸟嘌呤衍生物及其有机盐类化合物和药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US4801710A (en) * 1984-10-26 1989-01-31 Merck & Co., Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
US5723609A (en) * 1988-03-30 1998-03-03 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl purines

Also Published As

Publication number Publication date
GR3021277T3 (en) 1997-01-31
JP2829440B2 (ja) 1998-11-25
EP0523100A4 (en) 1993-03-17
EP0523100A1 (en) 1993-01-20
CA2078129C (en) 1999-05-04
DE69121706D1 (de) 1996-10-02
EP0523100B1 (en) 1996-08-28
DK0523100T3 (en, 2012) 1997-02-10
CA2078129A1 (en) 1991-09-14
AU646452B2 (en) 1994-02-24
DE69121706T2 (de) 1997-01-23
JPH05504972A (ja) 1993-07-29
WO1991013898A1 (en) 1991-09-19
US5352669A (en) 1994-10-04
AU7582191A (en) 1991-10-10
ATE141925T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
ES2091322T3 (es) Compuestos de guanina, guanosina y 2'-desoxiguanosina benciladas en o6 que poseen actividad de empobrecimiento en o6-alquilguanina-dna-alquiltransferasa.
ES2002254A4 (es) Nuevos 5-alcoxi-2,4-diamino-alquilbenzenos asi como tintes para el cabello con 5-alcoxi-2,4-diamino-alquil-benzenos.
ES8504128A1 (es) Procedimiento de preparar compuestos antiinflamatorios y anti-alergicos
ES340412A1 (es) Procedimiento para la preparacion de derivados de piroin- dol.
ES361530A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi 3-sec - alcohilamino propanos racemicos u opticamente activos.
PT702683E (pt) Derivados de guanina o6-substituida processo para a sua preparacao e sua utilizacao no tratamento de celulas tumorais
ES470787A1 (es) Procedimiento para preparar derivados de benzoquinolicina
IT1148725B (it) Immagazzinamento di combustibile idrogeno
ES545261A0 (es) Procedimiento para preparar 9-(propoximetil monosubstituido en 1-0 o en 3-0 o di-substituido en 1,3-0)-purinas substi- tuido en 1,3-0)-purinas substituidas como agentes antivira- les
ES450799A1 (es) Un procedimiento para la preparacion de nuevas 3-fenilespino(esobenzofuran-1,4'-piperidemo) sulfenamidas y derivados.
GB1250208A (en, 2012)
ES390532A1 (es) Procedimiento para la preparacion de una composicion herbi-cida a base de isoxazolpirimidinas sustituidas.
ES483003A1 (es) Procedimiento de preparacion de derivados de fenil-1-pipera-zina
SE395524B (sv) Innerkuggring for planetvexel i kompoundutforande for att minska ringens styvhet
IT1112322B (it) Struttura di supporto per cavi,particolarmente del tipo antisismico per centrali nucleari
BE605387A (fr) Perfectionnements apportés aux stations centrales génératrices d'énergie
ES8506577A1 (es) Procedimiento para preparar un derivado de ester de cefalosporina
ES8900163A1 (es) Un procedimiento para preparar derivados de tioxantenona
SE8400561L (sv) Hexanor-brassinolid-22-etrar, forfarande for framstellning av dessa foreningar samt medel innehallande dem med tillvextreglerande verkan for vexter
ES8608492A1 (es) Procedimiento para la obtencion de derivados de 3-(ureidociclohexilamino) propan-1, 2-diol
SE7407129L (en, 2012)
ES8609288A1 (es) Un procedimiento para preparar un derivado de tiazolidina
GB992222A (en) Hypoglycemic compositions containing acyl disulphides and their esters
FR2355844A1 (fr) Nouveaux composes pyrimido(1,2a)heterocycliques, procede de preparation de ces corps et compositions pharmaceutiques qui les contiennent
FR1276654A (fr) Nouveaux dérivés de l'hydroxy-4-alpha-2-pyrone

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 523100

Country of ref document: ES